[Immunity and immunization against foot-and-mouth disease (FMD) virus].

G. Wittmann

1972-08-01

Abstract:

What problem does this paper attempt to address?

Extragonadal Germ Cell Tumors: A Review With Emphasis on Pathologic Features, Clinical Prognostic Variables, and Differential Diagnostic Considerations

Jesse K. McKenney,Amy Heerema-McKenney,Robert V. Rouse,McKenney, Jesse K.,Rouse, Robert V.,Heerema-McKenney, Amy

DOI: https://doi.org/10.1097/PAP.0b013e31803240e6

2019-10-03

Advances in Anatomic Pathology

Abstract:Extragonadal germ cell tumors (GCTs) are relatively uncommon, but represent 1% to 5% of all GCTs. Their morphology varies widely and includes mature teratoma, immature teratoma, seminoma, yolk sac tumor, embryonal carcinoma, choriocarcinoma, and mixed GCTs. Noncentral nervous system extragonadal GCTs are found in a variety of anatomic locations, but most commonly affect the mediastinum and sacrococcygeal region. Predicting behavior in these tumors can be confusing because it is based on a combination of varying factors including patient age, histologic subtype, anatomic site, and clinical stage. This review attempts to dissect these issues by separating the discussion into 3 age groups: neonatal (congenital), children (prepubertal), and adult (postpubertal). Within each individual age group, we cover the significance of anatomic site, morphology, and staging parameters. In addition, we discuss the spectrum of associated secondary malignancies and their impact on patient outcome. Finally, we provide a detailed survey of differential diagnostic considerations grouped by anatomic site.

pathology
Extragonadal Germ Cell Tumors: A Single Institution Experience with Clinicopathological Correlation

Mithraa Devi Sekar,Immanuel Pradeep,Bheemanathi Hanuman Srinivas,Smita Kayal

DOI: https://doi.org/10.1177/10668969231201413

Abstract:Background. Extragonadal germ cell tumors (EGCTs) are a rare heterogeneous group of tumors without evidence of primary gonadal germ cell tumors. They account for 2%-5% of overall malignancies. EGCTs are often not clinically suspected, making them challenging for pathologists. In this retrospective observational study, we describe our institutional experience among EGCTs with clinicopathological correlation. Materials and methods. All patients diagnosed as EGCTs from January 2014 to April 2023 were collected. All relevant clinical data and serum markers were retrieved from hospital medical records. Histopathology and immunohistochemistry slides were reviewed. Results. The present study included a total of 56 patients; 34 (60%) men and 22 (40%) women with a men-to-women ratio of 1.5:1. Of them, 1 patient had congenital/neonatal EGCTs, 21 patients had prepubertal EGCTs, and 34 had post-pubertal EGCTs. The common sites included are mediastinum (45%), sacrococcyx (18%), retroperitoneum (14%), and central nervous system (12%). The other rare sites were the vagina, liver, colon, and duodenum. The common germ cell tumor included mature teratoma (34%), mixed germ cell tumor (27%), seminoma/germinoma (12%), pure yolk sac tumor (11%), immature teratoma (9%), mature teratoma with somatic tumor (5%), and embryonal carcinoma (2%). All histological diagnoses of germ cell tumors were confirmed with IHC markers like PLAP, CD117 (KIT), AFP, LIN28, CD30, and β-hCG. Pre and posttreatment serum tumor marker levels were available in 37 patients. All our treated patients had a decrease or normal tumor marker levels post-therapy. Conclusion. In our study, a heterogeneous group of germ cell tumors was seen. Most of them were seen in post-pubertal adolescents and young adults. Early intervention by platinum-based combination chemotherapy in seminoma and nonseminomatous germ cell tumors has significantly improved the prognosis of malignant EGCTs similar to their germ cell counterparts.
International Commission on Trichinellosis: recommendations on methods for the control of Trichinella in domestic and wild animals intended for human consumption.

H. Gamble,A. Bessonov,K. Čuperlović,A. Gajadhar,F. Knapen,K. Noeckler,H. Schenone,Xing-Quan Zhu

DOI: https://doi.org/10.1016/S0304-4017(00)00354-X

IF: 2.821

2000-12-01

Veterinary Parasitology

Abstract:
Recent advances in molecular biology and treatment strategies for intracranial germ cell tumors

Xiang Huang,Rong Zhang,Ying Mao,Liang-Fu Zhou,Chao Zhang

DOI: https://doi.org/10.1007/s12519-016-0021-2

2016-01-01

World Journal of Pediatrics

Abstract:Background Intracranial germ cell tumors (IGCTs) are a group of rare pediatric brain tumors which include various subtypes. The current understanding of the etiology of the tumors and their optimal management strategies remain controversial. Data sources The data on IGCTs were collected from articles published in the past 20 years, and the origin and etiology of IGCTs at molecular level as well as the relative roles of varied treatment strategies in different prognosis groups according to Matsutani’s classification were reviewed. Results Recent cellular and molecular evidence suggests that IGCTs may arise from the transformation of endogenous brain cells; and findings in the molecular characterization of IGCTs suggest roles of CCND2, RB1, and PRDM14 in the pathogenesis of IGCTs and identify the KIT/RAS and AKT1/mTOR pathways as potential therapeutic targets in future. According to Matsutani’s classification of IGCTs, the good prognosis group includes both germinomas and mature teratomas. For germinomas, both radiation alone and reduced-dose radiotherapy in combination with adjuvant chemotherapy are effective, while complete surgical excision is recommended for mature teratomas. In the intermediate prognosis group, immature teratoma has been successfully treated with gamma knife surgery. However, for intermediate prognosis IGCTs other than immature teratomas, gross total resection with adjuvant chemotherapy and radiotherapy or gamma knife surgery may be necessary to achieve cure. In the poor prognosis group, survival outcomes are unsatisfactory, and complete surgical resection combined with more intensive chemotherapy and radiotherapy remains the best available treatment option at this time. Conclusions IGCTs should be strictly classified according to their pathological categories before administering pathology-specific treatments. Although open microsurgical excision is the traditional surgical strategy for IGCTs, recent publications also support the role of endoscopic surgical options for pineal region IGCTs.
Reversible spastic and pyramidal tract signs in a patient with parkinson's disease on L-Dopa

S. Seyfert,M. Straschill

DOI: https://doi.org/10.1007/BF00313624

1977-10-07

Journal of Neurology

Abstract:
Management of Germ Cell Tumors in Pediatric Patients

Brent R Weil,Deborah F Billmire

DOI: https://doi.org/10.1016/j.soc.2020.11.011

Abstract:Germ cell tumors arise from primordial germ cells. Most develop in the gonads or along midline structures of the body. Genetic aberrations leading to disruption in the molecular signaling responsible for primordial germ cell migration early in development may provide rationale for why germ cell tumors originate in extragonadal locations. Establishing best practices for treating pediatric germ cell tumors remains an area of active investigation. Recent advances focused on limiting toxicities of therapy, identifying new therapies for relapsed and refractory tumors, defining best practices for surgical staging and resection, and developing novel methods to monitor for disease relapse.
Current outstanding challenges in germ cell tumors

Tareq Salous,Nabil Adra

DOI: https://doi.org/10.1097/cco.0000000000001026

2024-03-07

Current Opinion in Oncology

Abstract:Despite the remarkable advances in the treatment of germ cell tumors (GCT), several challenges remain. This review aims to highlight some of these challenges and provide guidance on how to navigate through them.

oncology
Cytopathologic diagnosis of extragonadal germ cell tumors: A 10-year institutional review

Daniel L Geisler,Mason Marshall,Sheldon I Bastacky,Samer N Khader

DOI: https://doi.org/10.1002/cncy.22761

Abstract:Background: The occurrence of extragonadal germ cell tumors (EGGCTs), either as primary tumors or metastatic disease, is rare. Forms of cytologic sampling, including fluid analysis, fine-needle aspiration, and/or small-core needle biopsy, have been shown to be reliable methods for the diagnosis of germ cell tumors. This study aims to investigate the utility of cytopathologic techniques in the diagnosis of EGGCTs at the authors' institution. Methods: The laboratory information system was queried over a period of 10 years (2012-2022) to identify all cytology cases diagnosed on fluid cytology, FNA, and/or small-core biopsy as germ cell tumors in extragonadal locations. Patient demographics, tumor location, serum tumor marker levels, cytopathologic diagnosis, and follow-up surgical resection data were reviewed and correlated. Results: A total of 35 cases from 32 patients (all males) were identified. Thirty specimens contained satisfactory material for diagnosis (86%) and five were less than optimal for evaluation (14%). Despite this, all cases had clinically useful cytopathologic diagnoses. A total of 19 cytology cases (16 patients) had follow-up resection specimens available. Of these, 11 patients underwent preoperative chemotherapy. Nine patients showed no evidence of residual tumor and two showed histologic concordance. Of the five patients who did not have preoperative chemotherapy, all showed concordant histologic diagnoses. Conclusions: Cytology can provide a reliable, accurate method for diagnosing EGGCTs. The practice of preoperative (neoadjuvant) chemotherapy places an extreme importance on the initial cytopathologic diagnosis because the majority of patients with follow-up resection in this series showed no residual tumor.
Diagnosis and Treatment of Intracranial Germ Cell Tumors (Clinical Analysis of 38 cases)

陈建松,陈衔城

DOI: https://doi.org/10.3969/j.issn.1009-153X.2002.01.011

2002-01-01

Abstract:Objective To explore the methods of the diagnosis and treatment for the intracranial germ cell tumors. Methods The data of 38 cases of the intracranial germ cell tumors confirmed by pathological examination during recent 10 years were reviewed. Results Thirty two tumors were excised by neurosurgery and another 6 cases only underwent biopsy. After the operation, 26 cases received radiotherapy and 4 of them received chemotherapy additionally. Follow-up findings of 18 cases, including the 4 received radiotherapy after the biopsy, demonstrated that all of them had returned to their normal life. Conclusion The priority is given to radiotherapy for the treatment of the intracranial germ cell tumors. The operation is aimed to verifing the nature of the tumor for radiotherapy or chemotherapy, and total excision is unnecessary except tor mature teratoma.
Outcomes and prognostic variables of extracranial germ cell tumors in children and adolescents treated over a decade: A developing world perspective

Subramaniam Ramanathan,Maya Prasad,Tushar Vora,Badira C Parambil,Seema Kembhavi,Mukta Ramadwar,Nehal Khanna,Siddhartha Laskar,Purna Kurkure,Sajid Qureshi,Shripad Banavali,Girish Chinnaswamy

DOI: https://doi.org/10.1002/pbc.29765

Abstract:Background: The purpose of this single-center study was to analyze the outcomes of extracranial germ cell tumors (GCTs) in children treated on a multimodality regimen. Methods: Retrospective study of children (<18 years) with a histopathologically confirmed diagnosis of extracranial GCT over a period of 10 years (January 2009 to December 2018) treated on a uniform institution-based protocol consisting of both cisplatin- and carboplatin-based regimens. All completely excised teratomas and stage I gonadal tumors received no further therapy (low risk [LR]); stage IV ovarian, stage III-IV extragonadal GCTs received six cycles of chemotherapy (high risk [HR]), and the remaining received four cycles of chemotherapy (intermediate risk [IR]). Results: A total of 297 children were treated with a female:male ratio of 1.72:1 and median age of 4 years. Forty-three children had pure teratomas. Gonadal GCTs (N = 180) were more common than extragonadal GCTs (N = 117) with ovary as primary site in 128 children (43%) and sacrococcygeal site being the commonest extragonadal location (N = 41; 14%). LR, IR, and HR disease were noted in 60 (20.2%), 125 (42%), and 112 (37.8%) patients, respectively. Three-fourths of ovarian tumors and half of testicular tumors operated prior to presentation needed upstaging. Forty-one patients relapsed and 43 children expired (disease-related: 33; toxic deaths: 9; unknown: 1). The 5-year event-free survival (EFS)/overall survival (OS) of malignant GCT (n = 254) was 72.50%/82.70%, respectively, with gonadal site (p = .001), LR and IR (p = .001) and nonmetastatic disease (p = .001) being favorable prognostic variables. Conclusions: The LR and IR GCTs in our cohort had an excellent outcome. A significant proportion of IR gonadal GCTs can be spared of systemic chemotherapy by adhering to strict surgical guidelines. In HR GCTs however, intensifying therapies to improve outcomes must be balanced against the risk of cumulative toxicity, more so in a resource-limited setting.
Perspectives on testicular germ cell neoplasms

Liang Cheng,Bingjian Lyu,Lawrence M Roth

DOI: https://doi.org/10.1016/j.humpath.2016.08.002

Abstract:Our knowledge of testicular germ cell neoplasms has progressed in the last few decades due to the description of germ cell neoplasia in situ (GCNIS) and a variety of specific forms of intratubular germ cell neoplasia, the discovery of isochromosome 12p and its importance in the development of invasiveness in germ cell tumors (GCTs), the identification of specific transcription factors for GCTs, and the recognition that a teratomatous component in mixed GCT represents terminal differentiation. Isochromosome 12p and 12p overrepresentation, collectively referred to as 12p amplification, are fundamental abnormalities that account for many types of malignant GCTs of the testis. Embryonal carcinoma is common in the testis but rare in the ovary, whereas the converse is true for mature cystic teratoma. Spermatocytic tumor occurs only in the testis; it has not been described in the ovary or extragonadal sites. The origin of ovarian mature cystic teratoma is similar to that of prepubertal-type testicular teratoma and dermoid cyst at any age in that it arises from a nontransformed germ cell, whereas postpubertal-type testicular teratoma arises from a malignant germ cell, most commonly through the intermediary of GCNIS. Somatic neoplasms, often referred to as monodermal teratomas, arise not infrequently from mature cystic teratoma of the ovary, whereas such neoplasms are rare in testicular teratoma with the exception of carcinoid. Integration of classical morphologic observations and emerging novel molecular studies will result in better understanding of the pathogenesis of GCTs and will optimize patient therapy.
Advances in genetic abnormalities, epigenetic reprogramming, and immune landscape of intracranial germ cell tumors

Yi Zhang,Chengyi Zhong,Xindi Ke,Jifang Liu,Zhang Ye,Lin Lu,Kan Deng,Huijuan Zhu,Yong Yao

DOI: https://doi.org/10.1186/s40478-023-01682-y

2023-11-27

Abstract:Intracranial germ cell tumors (IGCTs) are a rare subtype of central nervous system neoplasms that predominantly affect young individuals and exhibit a higher incidence in East Asia. IGCTs can be pathologically divided into two main categories: germinomas and non-germinomatous germ cell tumors (NGGCTs). Despite the scarcity of this disease, recent advancements in molecular biology techniques have facilitated the discovery of the inherent genetic and molecular characteristics of IGCTs. Somatic mutations that result in the activation of the KIT/RAS/MAPK and PI3K/AKT/mTOR pathways, chromosomal instability leading to characteristic changes in chromosomal fragments (notably 12p gain), and potentially diagnostic miRNAs (such as miR-371a-3p) may provide valuable insights for the efficient diagnosis, targeted therapy, and prognosis evaluation of IGCTs. Additionally, transcriptomic and methylomic analyses have provided new perspectives on the intrinsic development of IGCTs, further elucidating their equivalence with GCTs at other sites. The evaluation of the tumor immune landscape may guide prognosis prediction and immunotherapy for IGCT patients. Nevertheless, current research still faces challenges such as the absence of basic laboratory research systems, a single source of large sample research data, and a limited overall volume of research. The incorporation of larger sample sizes, the implementation of more innovative evaluation systems, and the employment of novel experimental methods are urgently required to become the focus of future research.
Surgical Challenges and Outcomes in Management of Benign Retroperitoneal Germ Cell Tumors—A Tertiary Care Centre Experience

Apoorv Singh,Vishesh Jain,Anjan Kumar Dhua,Prabudh Goel,Sameer Bakhshi,Venkateswaran K. Iyer,Devasenathipathy Kandasamy,Manisha Jana,Sandeep Agarwala

DOI: https://doi.org/10.1007/s12262-024-04179-7

2024-10-26

Indian Journal of Surgery

Abstract:Germ cell tumors (GCTs) arise from primordial germ cells and can occur in any region along the path of migrating primordial germ cells. Retroperitoneal teratomas are such tumors usually arising in para-renal locations. These tumors have the propensity to grow to large sizes leading to distortion of the local anatomy and compressive symptoms. Surgical excision of these tumors is challenging, with high complication rates. Retrospective data of all the patients with retroperitoneal GCTs, managed from January 1998 through March 2020, was included. Patients with increased alpha-fetoprotein or with malignant histopathology were excluded. Maintained data sets of the included patients were evaluated for patient demographics, symptoms, radiologic and histologic findings, surgical procedures and postoperative outcomes. A total of 26 patients of retroperitoneal GCTs, comprising ten males and 16 females, were operated on at our centre. The median age at presentation was 10.5 months (1 day to 178 months). Most patients ( n = 21/26) presented with a palpable abdominal mass. All the patients underwent operative intervention. Intraoperatively, 23% of patients had a tumor in close proximity to major vessels, while bowel involvement was present in 12%. Immature teratoma was present on histopathology in 15% of the patients. The median duration of follow-up was 24 months (1–168 months), and there were no recurrences reported in the cohort. Retroperitoneal GCTs have an excellent outcome if completely excised. The current study highlights the need for adequate preoperative evaluation and intraoperative visualization of the vital structures to achieve complete excision in these patients.

surgery
Our daily rounds of activity and temperature.

F. Yates

DOI: https://doi.org/10.1152/ajpregu.1982.242.1.R1

Abstract:
Clinical Challenges in the Management of Malignant Ovarian Germ Cell Tumours

Iqra Saani,Nitish Raj,Raja Sood,Shahbaz Ansari,Haider Abbas Mandviwala,Elisabet Sanchez,Stergios Boussios

DOI: https://doi.org/10.3390/ijerph20126089

2023-06-09

Abstract:Nonepithelial ovarian cancers (NEOC) are a group of rare malignancies, including germ cell tumours (GCT) and sex cord-stromal tumours (SCST), along with small-cell carcinomas and sarcomas. GCTs represent 2-5% of ovarian cancers, with a yearly incidence of 4:100,000, and they usually affect young women and adolescents. Precursory germ cells of the ovary form the basis of GCT. They are histologically classified into primitive GCT, teratomas, and monodermal and somatic-type tumours associated with dermoid cysts. A primitive GCT can be either a yolk sac tumour (YST), dysgerminoma, or mixed germ cell neoplasm. Teratomas are either mature (benign) or immature (malignant). Given that malignant GCTs occur rarely compared to epithelial ovarian tumours (EOC), greater focus is required in their diagnosis and treatment. In this article, we review the epidemiology, clinical manifestations, diagnosis, and molecular biology, along with the management and therapeutic challenges.
Extracranial Germ Cell Tumors in Children: Ten Years of Experience in Three Children's Medical Centers in Shanghai

Shayi Jiang,Kuiran Dong,Kai Li,Jiangbin Liu,Xin Du,Can Huang,Yangyang Jiao,Yali Han,Jingwei Yang,Xuelian Liao,Yanhua Li,Ting Zhang,Shanshan Li,Zhibao Lv,Yijin Gao

DOI: https://doi.org/10.3390/cancers15225412

2023-11-14

Abstract:Objective: The aim was to describe the clinical features of extracranial germ cell tumors (GCTs) in pediatrics and study the clinical risk factors related to survival for malignant germ cell tumors (MGCTs) in order to optimize therapeutic options. Methods: The clinical data of children with extracranial GCTs in three children's medical centers in Shanghai were retrospectively analyzed. Results: In total, 1007 cases of extracranial GCTs diagnosed between 2010 and 2019 were included in this study, including teratomas (TERs) 706 (70.11%) and MGCTs 301 (29.89%). There were twice as many TER cases as MGCT cases. Approximately 50% of children with GCTs were <3 years old (43.39% for TERs, 67.13% for MGCTs). GCTs in children of different ages show differences in tumor anatomical locations and pathological subtypes. The 5-year event-free survival (EFS) and overall survival (OS) of all patients with MGCTs were 82.33% (95% CI, 77.32%, 86.62%) and 94.13% (95% CI, 90.02%, 96.69%), respectively. The multivariate Cox regression analysis identified a primary site in the mediastinum and alpha fetoprotein (AFP) levels ≥10,000 ng/mL as independent adverse prognostic factors (p < 0.0.0001, χ2 = 23.6638, p = 0.0225, χ2 = 5.2072.). There were no significant differences in OS among children receiving various chemotherapy regimens, such as the BEP, PEB, JEB and other regimens (VBP/VIP and AVCP/IEV) (p < 0.05). Conclusions: The clinical features of GCTs in Chinese pediatrics are similar to those reported in children in Europe and America. The age distribution of pathological types and primary sites in GCTs reflect the developmental origin of type I and type II GCTs transformed from mismigration primordial germ cells (PGCs). Optimizing the current platinum-based chemotherapy regimens and exploring the treatment strategies for MGCTs of the mediastinum are future research directions.
Lethal Subtypes of a Curable Cancer

Jamaal C. Jackson,Darren Sanchez,Andrew C. Johns,Matthew T. Campbell,Ahmet M. Aydin,Neriman Gokden,Sanjay Maraboyina,Jason L. Muesse,John F. Ward,Louis L. Pisters,Niki M. Zacharias,Charles C. Guo,Shi-Ming Tu

DOI: https://doi.org/10.3390/jcm13123436

IF: 3.9

2024-06-13

Journal of Clinical Medicine

Abstract:Germ cell tumor of the testis (GCT) is a curable cancer even when it is widely metastatic; however, outcomes can differ based on tumor histology. Chemo-resistance in certain phenotypes, such as teratoma and yolk sac tumor, contributes to poor clinical outcomes in some patients with GCT. Despite this resistance to S-YSTemic therapy, many of these tumor subtypes remain amenable to surgical resection and possible cure. In this study, we report on a series of seven patients highlighting two chemo-resistant subtypes of nonseminomatous germ cell tumor (NSGCT), sarcomatoid yolk sac tumor (S-YST), and epithelioid trophoblastic tumor (ETT) for which early resection rather than additional salvage chemotherapy or high-dose intense chemotherapy might provide a superior clinical outcome and enhance cure rate.

medicine, general & internal
Current Strategy for the Treatment of Ovarian Germ Cell Tumors: Role of Extensive Surgery

Jin Li,Xiaohua Wu

DOI: https://doi.org/10.1007/s11864-016-0416-2

2016-01-01

Current Treatment Options in Oncology

Abstract:The necessity and extent of comprehensive surgical staging (CSS) and lymphadenectomy in the treatment of malignant ovarian germ cell tumors (MOGCTs) is still controversial. However, it is uniformly agreed that CSS with lymphadenectomy is crucial to follow up patients without adjuvant chemotherapy in stage I MOGCTs. Considering the chemotherapy-sensitive nature of MOGCTs, fertility-sparing cytoreductive surgery (FSCS) seems a reasonable approach in initial treatment for patients with advanced stage. When encountered with bilateral MOGCTs, debulking is surely granted if there is no desire for fertility. Both ovaries completely replaced by neoplastic tissue composed the most challenging situation especially when patients require childbearing potential. In dysgerminoma histology, which usually has good prognosis, residual disease could be left to spare fertility. USO of the largest and more heterogeneous ovarian mass and a biopsy of the contralateral lesion may be considered if the patients are compliant to regular follow-up. NACT followed by interval FSCS may be a reasonable option in patients with extensive disease, when initial debulking is not an option or where the poor general condition or clinical findings suggest an increased risk of surgical morbidity or preclude fertility-sparing surgery. This is currently not the standard of care but deserves future study. In some rare situation, when any remaining ovarian tissue means high risk, BSO may be performed with the uterus preserved for possible assisted reproduction with donor egg. Treatment failure occurs in a small group of MOGCTs after primary treatment. A good number of recurrences can be salvaged with selected salvage surgery, especially when optimal secondary cytoreduction can be achieved. Immature teratoma is a subtype of MOGCTs where secondary cytoreduction may have a strong role to play.
Individualized treatment of intracranial germ cell tumors

Yapeng Zhao,Yuqi Zhang,Hongyu Duan,Yu Ma,Hui Liang,Qinghui Zhang,Chaoqiang Xue,Bin Luo,Xin Pan

DOI: https://doi.org/10.3760/cma.j.issn.1001-2346.2017.03.008

2017-01-01

Abstract:Objective To analyze the treatment effects of intracranial germ cell tumors (ICGCTs) using microsurgery.Methods A retrospective study was conducted on the data of 32 cases of ICGCT who were admitted to Yuquan Hospital of Tsinghua University from October 2012 to June 2016.Among them,there were 6 cases of germinoma,14 cases of mixed ICGCT,4 cases of mature teratoma,6 cases of immature teratoma,1 case of malignant teratoma and 1 case of choriocarcinoma.Preoperative chemotherapy was performed in 4 cases.Postoperatively,16 cases received chemotherapy,3 cases underwent local radiotherapy,and 2 cases underwent chemotherapy plus local radiotherapy.The surgical outcomes were followed up.Results For the 32 cases,the average follow-up period was (21.8 ±13.5) months.The gross total resection (GTR) group included 17 cases (53.1％) and the remaining 15 cases (46.9％) did not receive GTR.Out of the 12 patients of tumor recurrence,3 cases (25.0％) belonged to the GTR group and the other 9 cases (75.0％) were in the non-GTR group.The recurrence rates in the two groups (3/17 vs.9/15) were significantly different (P ＜0.05).Pathological results indicated that the "teratoma" components were contained in 22 cases,accounting for 66.8％ of all cases in this study and 84.6％ of non-germinoma of germ cell tumors (NGGCTs).In 2 cases of tumor recurrence,their pathological results were inconsistent with the original features.No severe surgical complications were observed.By the end of follow-up,6 patients (18.8％) died,among whom 5 did not receive postoperative chemoradiotherapy and died from tumor recurrence.Conclusions Microsurgery seems to be one important approach in treatment of ICGCTs,particularly NGGCTs.Patients might benefit from the GTR of the lesions.Individualized radiation and chemotherapy before and after surgery could help reduce the tumor recurrence.
Surgical Treatment for Pelvic Giant Cell Tumor: a Multi-Center Study.

Kai Zheng,Xiuchun Yu,Yongcheng Hu,Zhen Wang,Sujia Wu,Zhaoming Ye

DOI: https://doi.org/10.1186/s12957-016-0862-0

2016-01-01

World Journal of Surgical Oncology

Abstract:Background: The purpose of this study was to discuss the clinical results which related to the location of giant cell tumors (GCTs) in the pelvis so as to determine the ideal surgical treatment protocol.Methods: We report 29 cases who accepted surgical treatment from five clinical centers during the last 12 years. All patients were divided into three groups according to tumor locations, and they were also classified into two groups in light of surgical treatments. The parameters for outcome evaluation consisting of general condition, surgical complications, local disease control, and Musculoskeletal Tumor Society (MSTS) 93 functional score had been analyzed, respectively.Results: Surgical treatment in the acetabular area usually resulted in postoperative complications and poor function. One patient who accepted intralesional surgery and two who accepted wide resection had local recurrence. The mean functional score was 25.4 for the 8 patients who received intralesional surgery and 21.9 for the 21 patients who received wide resection. Surgical complications occurred in 1 patient who underwent intralesional surgery and the other 6 patients who underwent wide resection.Conclusions: We conclude that surgical treatment of pelvic GCTs in the acetabular area is difficult to select as it is always accompanied by complications and poor function. Compared to wide resection, intralesional surgery combined with a meticulous preoperative planning may lower the recurrence rate and obtain favorable postoperative functional results.

[Immunity and immunization against foot-and-mouth disease (FMD) virus].

Extragonadal Germ Cell Tumors: A Review With Emphasis on Pathologic Features, Clinical Prognostic Variables, and Differential Diagnostic Considerations

Extragonadal Germ Cell Tumors: A Single Institution Experience with Clinicopathological Correlation

International Commission on Trichinellosis: recommendations on methods for the control of Trichinella in domestic and wild animals intended for human consumption.

Recent advances in molecular biology and treatment strategies for intracranial germ cell tumors

Reversible spastic and pyramidal tract signs in a patient with parkinson's disease on L-Dopa

Management of Germ Cell Tumors in Pediatric Patients

Current outstanding challenges in germ cell tumors

Cytopathologic diagnosis of extragonadal germ cell tumors: A 10-year institutional review

Diagnosis and Treatment of Intracranial Germ Cell Tumors (Clinical Analysis of 38 cases)

Outcomes and prognostic variables of extracranial germ cell tumors in children and adolescents treated over a decade: A developing world perspective

Perspectives on testicular germ cell neoplasms

Advances in genetic abnormalities, epigenetic reprogramming, and immune landscape of intracranial germ cell tumors

Surgical Challenges and Outcomes in Management of Benign Retroperitoneal Germ Cell Tumors—A Tertiary Care Centre Experience

Our daily rounds of activity and temperature.

Clinical Challenges in the Management of Malignant Ovarian Germ Cell Tumours

Extracranial Germ Cell Tumors in Children: Ten Years of Experience in Three Children's Medical Centers in Shanghai

Lethal Subtypes of a Curable Cancer

Current Strategy for the Treatment of Ovarian Germ Cell Tumors: Role of Extensive Surgery

Individualized treatment of intracranial germ cell tumors

Surgical Treatment for Pelvic Giant Cell Tumor: a Multi-Center Study.